Literature DB >> 3321379

Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67.

P A Lalor1, P I Mapp, P A Hall, P A Revell.   

Abstract

The presence of proliferating cells has been sought in the synovium of rheumatoid arthritic (RA) and osteoarthritic (OA) joints using the monoclonal antibody Ki67, which marks a nuclear antigen present in all stages of the cell cycle apart from Go. Synovia were studied from 21 RA and 14 OA cases using the indirect immunoperoxidase technique. Double-staining was performed on 18 RA and 17 OA synovia with the simultaneous labelling of lysozyme (muramidase) by the immuno-alkaline phosphatase method and with Ki67 by the indirect immunoperoxidase method. Most of the RA and OA synovia showed an absence of Ki67-positive cells in the intimal cell layer. Three RA and four OA synovia showed no more than ten proliferating cells in the whole of the intimal layer examined. Similar results were obtained when double-labelling was performed. Eight RA and six OA synovia showed the presence of occasional Ki67-positive cells in the intimal layer. The total number of intimal cells was measured for each histological section, and the proliferation index calculated as the percentage of total cells in the intimal layer showing Ki67-positive staining. This varied between 0.03% and 0.0033% (between 1:2800 and 1:30,000 cells). In contrast, there were plentiful Ki67-positive cells present in the lymphocytic infiltrate and around blood vessels in the RA synovia and in the synovial infiltrate, where present, in the OA cases.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3321379     DOI: 10.1007/BF00541375

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  12 in total

1.  Proliferation of synovial lining cells and fibroblasts.

Authors:  W Mohr; G Beneke; W Mohing
Journal:  Ann Rheum Dis       Date:  1975-06       Impact factor: 19.103

2.  Ultrastructural localisation of muramidase in the human synovial membrane.

Authors:  P I Mapp; P A Revell
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

3.  The fine structure of normal synovium in the dog as compared with the synovium after transplantation of a total knee joint.

Authors:  M F Bierther; K W Wegner; H Fackeldey
Journal:  Z Rheumaforsch       Date:  1972 Jul-Aug

4.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

5.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

6.  Origin of synovial type A cells during inflammation. An experimental approach.

Authors:  R Dreher
Journal:  Immunobiology       Date:  1982-04       Impact factor: 3.144

7.  Demonstration of bone marrow derived cells in synovial lining by means of giant intracellular granules as genetic markers.

Authors:  J C Edwards; D A Willoughby
Journal:  Ann Rheum Dis       Date:  1982-04       Impact factor: 19.103

8.  Mononuclear phagocytes of normal and rheumatoid synovial membrane identified by monoclonal antibodies.

Authors:  N Hogg; D G Palmer; P A Revell
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

9.  DNA synthesis in human rheumatoid and nonrheumatoid synovial lining.

Authors:  L A Coulton; B Henderson; L Bitensky; J Chayen
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

10.  Electron microscopy of the human synovial membrane.

Authors:  P BARLAND; A B NOVIKOFF; D HAMERMAN
Journal:  J Cell Biol       Date:  1962-08       Impact factor: 10.539

View more
  38 in total

Review 1.  Synovial lining cells.

Authors:  P A Revell
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

Review 2.  The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses.

Authors:  Peter A Revell
Journal:  J R Soc Interface       Date:  2008-11-06       Impact factor: 4.118

3.  Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis.

Authors:  O FitzGerald; M Soden; G Yanni; R Robinson; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 4.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

5.  Detection of p53 in inflammatory tissue and lymphocytes using immunohistology and flow cytometry: a critical comment.

Authors:  A Nickels; H Selter; M Pfreundschuh; M Montenarh; B Koch
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

6.  Immunohistochemical analysis of proliferating and antigen-presenting cells in rheumatoid synovial tissue.

Authors:  V Krenn; N Schalhorn; A Greiner; R Molitoris; A König; F Gohlke; H K Müller-Hermelink
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

7.  Ultrastructural characterisation of macrophages (type A cells) in the synovial lining.

Authors:  P I Mapp; P A Revell
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

Review 8.  Synovial lining cell hyperplasia in rheumatoid arthritis: dogma and fact.

Authors:  B Henderson; P A Revell; J C Edwards
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

Review 9.  Role of endothelium in chronic inflammation.

Authors:  M Ziff
Journal:  Springer Semin Immunopathol       Date:  1989

10.  Effect of three animal models of inflammation on nerve fibres in the synovium.

Authors:  P I Mapp; D A Walsh; N E Garrett; B L Kidd; S C Cruwys; J M Polak; D R Blake
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.